Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Cellulite Treatment Market, by Gender
1.4.2 North America Cellulite Treatment Market, by Procedure Type
1.4.3 North America Cellulite Treatment Market, by Cellulite Type
1.4.4 North America Cellulite Treatment Market, by End User
1.4.5 North America Cellulite Treatment Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. Recent Strategies Deployed in Cellulite Treatment Market
Chapter 5. North America Cellulite Treatment Market by Gender
5.1 North America Female Market by Region
5.2 North America Male Market by Region
Chapter 6. North America Cellulite Treatment Market by Procedure Type
6.1 North America Non-invasive Market by Country
6.2 North America Topical Market by Country
6.3 North America Minimally Invasive Market by Country
Chapter 7. North America Cellulite Treatment Market by Cellulite Type
7.1 North America Soft Cellulite Market by Country
7.2 North America Hard Cellulite Market by Country
7.3 North America Edematous Market by Country
Chapter 8. North America Cellulite Treatment Market by End User
8.1 North America Clinics & Beauty Centers Market by Country
8.2 North America Hospitals Market by Country
8.3 North America Others Market by Country
Chapter 9. North America Cellulite Treatment Market by Country
9.1 US Cellulite Treatment Market
9.1.1 US Cellulite Treatment Market by Gender
9.1.2 US Cellulite Treatment Market by Procedure Type
9.1.3 US Cellulite Treatment Market by Cellulite Type
9.1.4 US Cellulite Treatment Market by End User
9.2 Canada Cellulite Treatment Market
9.2.1 Canada Cellulite Treatment Market by Gender
9.2.2 Canada Cellulite Treatment Market by Procedure Type
9.2.3 Canada Cellulite Treatment Market by Cellulite Type
9.2.4 Canada Cellulite Treatment Market by End User
9.3 Mexico Cellulite Treatment Market
9.3.1 Mexico Cellulite Treatment Market by Gender
9.3.2 Mexico Cellulite Treatment Market by Procedure Type
9.3.3 Mexico Cellulite Treatment Market by Cellulite Type
9.3.4 Mexico Cellulite Treatment Market by End User
9.4 Rest of North America Cellulite Treatment Market
9.4.1 Rest of North America Cellulite Treatment Market by Gender
9.4.2 Rest of North America Cellulite Treatment Market by Procedure Type
9.4.3 Rest of North America Cellulite Treatment Market by Cellulite Type
9.4.4 Rest of North America Cellulite Treatment Market by End User
Chapter 10. Company Profiles
10.1 Candela corporation (Syneron Medical)
10.1.1 Company Overview
10.1.2 Recent strategies and developments:
10.1.2.1 Partnerships, Collaborations, and Agreements:
10.1.2.2 Product Launches and Product Expansions:
10.1.3 SWOT Analysis
10.2 Bausch Health Companies, Inc
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expense
10.2.5 Recent strategies and developments:
10.2.5.1 Trials and Approvals:
10.2.6 SWOT Analysis
10.3 Sinclair Pharma Ltd. (Huadong Medicine Co., Ltd.)
10.3.1 Company Overview
10.3.2 Recent strategies and developments:
10.3.2.1 Partnerships, Collaborations, and Agreements:
10.3.2.2 Product Launches and Product Expansions:
10.3.3 SWOT Analysis
10.4 AbbVie, Inc.
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Regional Analysis
10.4.4 Research & Development Expense
10.4.5 Recent strategies and developments:
10.4.5.1 Product Launches and Product Expansions:
10.4.5.2 Acquisition and Mergers:
10.4.6 SWOT Analysis
10.5 Hologic, Inc.
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expenses
10.5.5 SWOT Analysis
10.6 Galderma S.A.
10.6.1 Company Overview
10.6.2 SWOT Analysis
10.7 Endo International PLC
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Segmental Analysis
10.7.4 Research & Development Expense
10.7.5 Recent strategies and developments:
10.7.5.1 Trials and Approvals:
10.7.5.2 Acquisition and Mergers:
10.7.6 SWOT Analysis
10.8 Merz Pharma GmbH & Co. KGaA
10.8.1 Company Overview
10.8.2 SWOT Analysis
10.9 Cynosure, LLC (Clayton, Dubilier & Rice, LLC)
10.9.1 Company Overview
10.9.2 SWOT Analysis
10.10. Zimmer MedizinSysteme GmbH
10.10.1 Company Overview
10.10.2 SWOT Analysis
Unique Offerings 